Anavex Life Sciences Corp (AVXL)

[georgejjl]

Anavex is in discussions with FDA regarding Blarcamesine for the treatment of Rett syndrome

Hi. Thank you for taking my questions. First question on the adult AVATAR Rett study. Do we have an idea if when you're having a deep conversation and if the trial size needs to be modified to turn into a pivotal trial? If you can give us any color on that.

And also some color on the dosing for both the AVATAR and EXCELLENCE studies, what kind of those cohorts are should we expect?

Christopher Missling -- President and Chief Executive Officer

Right. So we are in a dialogue right now with the agency. We have foster designation and orphan drug designation, as well as the voucher eligibility for Rett syndrome with ANAVEX 2-73. So we're right now in dialogue with the agency.

https://www.google.com/amp/s/www.fool.com/amp/earnings/call-transcripts/2021/08/13/anavex-life-sciences-avxl-q3-2021-earnings-call-tr/

The. voucher should alone should be worth over $100 million.

Good luck and GOD bless,